Cargando…
Antibiotic Resistance Prevalence and Trends in Patients Infected with Helicobacter pylori in the Period 2013–2020: Results of the European Registry on H. pylori Management (Hp-EuReg)
Background: Bacterial antibiotic resistance changes over time depending on multiple factors; therefore, it is essential to monitor the susceptibility trends to reduce the resistance impact on the effectiveness of various treatments. Objective: To conduct a time-trend analysis of Helicobacter pylori...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471667/ https://www.ncbi.nlm.nih.gov/pubmed/34572640 http://dx.doi.org/10.3390/antibiotics10091058 |
_version_ | 1784574527034884096 |
---|---|
author | Bujanda, Luis Nyssen, Olga P. Vaira, Dino Saracino, Ilaria M. Fiorini, Giulia Lerang, Frode Georgopoulos, Sotirios Tepes, Bojan Heluwaert, Frederic Gasbarrini, Antonio Rokkas, Theodore Bordin, Dmitry Smith, Sinead Lamy, Vincent Caldas, María Resina, Elena Muñoz, Raquel Cosme, Ángel Puig, Ignasi Megraud, Francis O’Morain, Colm Gisbert, Javier P. |
author_facet | Bujanda, Luis Nyssen, Olga P. Vaira, Dino Saracino, Ilaria M. Fiorini, Giulia Lerang, Frode Georgopoulos, Sotirios Tepes, Bojan Heluwaert, Frederic Gasbarrini, Antonio Rokkas, Theodore Bordin, Dmitry Smith, Sinead Lamy, Vincent Caldas, María Resina, Elena Muñoz, Raquel Cosme, Ángel Puig, Ignasi Megraud, Francis O’Morain, Colm Gisbert, Javier P. |
author_sort | Bujanda, Luis |
collection | PubMed |
description | Background: Bacterial antibiotic resistance changes over time depending on multiple factors; therefore, it is essential to monitor the susceptibility trends to reduce the resistance impact on the effectiveness of various treatments. Objective: To conduct a time-trend analysis of Helicobacter pylori resistance to antibiotics in Europe. Methods: The international prospective European Registry on Helicobacter pylori Management (Hp-EuReg) collected data on all infected adult patients diagnosed with culture and antimicrobial susceptibility testing positive results that were registered at AEG-REDCap e-CRF until December 2020. Results: Overall, 41,562 patients were included in the Hp-EuReg. Culture and antimicrobial susceptibility testing were performed on gastric biopsies of 3974 (9.5%) patients, of whom 2852 (7%) were naive cases included for analysis. The number of positive cultures decreased by 35% from the period 2013–2016 to 2017–2020. Concerning naïve patients, no antibiotic resistance was found in 48% of the cases. The most frequent resistances were reported against metronidazole (30%), clarithromycin (25%), and levofloxacin (20%), whereas resistances to tetracycline and amoxicillin were below 1%. Dual and triple resistances were found in 13% and 6% of the cases, respectively. A decrease (p < 0.001) in the metronidazole resistance rate was observed between the 2013–2016 (33%) and 2017–2020 (24%) periods. Conclusion: Culture and antimicrobial susceptibility testing for Helicobacter pylori are scarcely performed (<10%) in Europe. In naïve patients, Helicobacter pylori resistance to clarithromycin remained above 15% throughout the period 2013–2020 and resistance to levofloxacin, as well as dual or triple resistances, were high. A progressive decrease in metronidazole resistance was observed. |
format | Online Article Text |
id | pubmed-8471667 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84716672021-09-28 Antibiotic Resistance Prevalence and Trends in Patients Infected with Helicobacter pylori in the Period 2013–2020: Results of the European Registry on H. pylori Management (Hp-EuReg) Bujanda, Luis Nyssen, Olga P. Vaira, Dino Saracino, Ilaria M. Fiorini, Giulia Lerang, Frode Georgopoulos, Sotirios Tepes, Bojan Heluwaert, Frederic Gasbarrini, Antonio Rokkas, Theodore Bordin, Dmitry Smith, Sinead Lamy, Vincent Caldas, María Resina, Elena Muñoz, Raquel Cosme, Ángel Puig, Ignasi Megraud, Francis O’Morain, Colm Gisbert, Javier P. Antibiotics (Basel) Article Background: Bacterial antibiotic resistance changes over time depending on multiple factors; therefore, it is essential to monitor the susceptibility trends to reduce the resistance impact on the effectiveness of various treatments. Objective: To conduct a time-trend analysis of Helicobacter pylori resistance to antibiotics in Europe. Methods: The international prospective European Registry on Helicobacter pylori Management (Hp-EuReg) collected data on all infected adult patients diagnosed with culture and antimicrobial susceptibility testing positive results that were registered at AEG-REDCap e-CRF until December 2020. Results: Overall, 41,562 patients were included in the Hp-EuReg. Culture and antimicrobial susceptibility testing were performed on gastric biopsies of 3974 (9.5%) patients, of whom 2852 (7%) were naive cases included for analysis. The number of positive cultures decreased by 35% from the period 2013–2016 to 2017–2020. Concerning naïve patients, no antibiotic resistance was found in 48% of the cases. The most frequent resistances were reported against metronidazole (30%), clarithromycin (25%), and levofloxacin (20%), whereas resistances to tetracycline and amoxicillin were below 1%. Dual and triple resistances were found in 13% and 6% of the cases, respectively. A decrease (p < 0.001) in the metronidazole resistance rate was observed between the 2013–2016 (33%) and 2017–2020 (24%) periods. Conclusion: Culture and antimicrobial susceptibility testing for Helicobacter pylori are scarcely performed (<10%) in Europe. In naïve patients, Helicobacter pylori resistance to clarithromycin remained above 15% throughout the period 2013–2020 and resistance to levofloxacin, as well as dual or triple resistances, were high. A progressive decrease in metronidazole resistance was observed. MDPI 2021-09-01 /pmc/articles/PMC8471667/ /pubmed/34572640 http://dx.doi.org/10.3390/antibiotics10091058 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Bujanda, Luis Nyssen, Olga P. Vaira, Dino Saracino, Ilaria M. Fiorini, Giulia Lerang, Frode Georgopoulos, Sotirios Tepes, Bojan Heluwaert, Frederic Gasbarrini, Antonio Rokkas, Theodore Bordin, Dmitry Smith, Sinead Lamy, Vincent Caldas, María Resina, Elena Muñoz, Raquel Cosme, Ángel Puig, Ignasi Megraud, Francis O’Morain, Colm Gisbert, Javier P. Antibiotic Resistance Prevalence and Trends in Patients Infected with Helicobacter pylori in the Period 2013–2020: Results of the European Registry on H. pylori Management (Hp-EuReg) |
title | Antibiotic Resistance Prevalence and Trends in Patients Infected with Helicobacter pylori in the Period 2013–2020: Results of the European Registry on H. pylori Management (Hp-EuReg) |
title_full | Antibiotic Resistance Prevalence and Trends in Patients Infected with Helicobacter pylori in the Period 2013–2020: Results of the European Registry on H. pylori Management (Hp-EuReg) |
title_fullStr | Antibiotic Resistance Prevalence and Trends in Patients Infected with Helicobacter pylori in the Period 2013–2020: Results of the European Registry on H. pylori Management (Hp-EuReg) |
title_full_unstemmed | Antibiotic Resistance Prevalence and Trends in Patients Infected with Helicobacter pylori in the Period 2013–2020: Results of the European Registry on H. pylori Management (Hp-EuReg) |
title_short | Antibiotic Resistance Prevalence and Trends in Patients Infected with Helicobacter pylori in the Period 2013–2020: Results of the European Registry on H. pylori Management (Hp-EuReg) |
title_sort | antibiotic resistance prevalence and trends in patients infected with helicobacter pylori in the period 2013–2020: results of the european registry on h. pylori management (hp-eureg) |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471667/ https://www.ncbi.nlm.nih.gov/pubmed/34572640 http://dx.doi.org/10.3390/antibiotics10091058 |
work_keys_str_mv | AT bujandaluis antibioticresistanceprevalenceandtrendsinpatientsinfectedwithhelicobacterpyloriintheperiod20132020resultsoftheeuropeanregistryonhpylorimanagementhpeureg AT nyssenolgap antibioticresistanceprevalenceandtrendsinpatientsinfectedwithhelicobacterpyloriintheperiod20132020resultsoftheeuropeanregistryonhpylorimanagementhpeureg AT vairadino antibioticresistanceprevalenceandtrendsinpatientsinfectedwithhelicobacterpyloriintheperiod20132020resultsoftheeuropeanregistryonhpylorimanagementhpeureg AT saracinoilariam antibioticresistanceprevalenceandtrendsinpatientsinfectedwithhelicobacterpyloriintheperiod20132020resultsoftheeuropeanregistryonhpylorimanagementhpeureg AT fiorinigiulia antibioticresistanceprevalenceandtrendsinpatientsinfectedwithhelicobacterpyloriintheperiod20132020resultsoftheeuropeanregistryonhpylorimanagementhpeureg AT lerangfrode antibioticresistanceprevalenceandtrendsinpatientsinfectedwithhelicobacterpyloriintheperiod20132020resultsoftheeuropeanregistryonhpylorimanagementhpeureg AT georgopoulossotirios antibioticresistanceprevalenceandtrendsinpatientsinfectedwithhelicobacterpyloriintheperiod20132020resultsoftheeuropeanregistryonhpylorimanagementhpeureg AT tepesbojan antibioticresistanceprevalenceandtrendsinpatientsinfectedwithhelicobacterpyloriintheperiod20132020resultsoftheeuropeanregistryonhpylorimanagementhpeureg AT heluwaertfrederic antibioticresistanceprevalenceandtrendsinpatientsinfectedwithhelicobacterpyloriintheperiod20132020resultsoftheeuropeanregistryonhpylorimanagementhpeureg AT gasbarriniantonio antibioticresistanceprevalenceandtrendsinpatientsinfectedwithhelicobacterpyloriintheperiod20132020resultsoftheeuropeanregistryonhpylorimanagementhpeureg AT rokkastheodore antibioticresistanceprevalenceandtrendsinpatientsinfectedwithhelicobacterpyloriintheperiod20132020resultsoftheeuropeanregistryonhpylorimanagementhpeureg AT bordindmitry antibioticresistanceprevalenceandtrendsinpatientsinfectedwithhelicobacterpyloriintheperiod20132020resultsoftheeuropeanregistryonhpylorimanagementhpeureg AT smithsinead antibioticresistanceprevalenceandtrendsinpatientsinfectedwithhelicobacterpyloriintheperiod20132020resultsoftheeuropeanregistryonhpylorimanagementhpeureg AT lamyvincent antibioticresistanceprevalenceandtrendsinpatientsinfectedwithhelicobacterpyloriintheperiod20132020resultsoftheeuropeanregistryonhpylorimanagementhpeureg AT caldasmaria antibioticresistanceprevalenceandtrendsinpatientsinfectedwithhelicobacterpyloriintheperiod20132020resultsoftheeuropeanregistryonhpylorimanagementhpeureg AT resinaelena antibioticresistanceprevalenceandtrendsinpatientsinfectedwithhelicobacterpyloriintheperiod20132020resultsoftheeuropeanregistryonhpylorimanagementhpeureg AT munozraquel antibioticresistanceprevalenceandtrendsinpatientsinfectedwithhelicobacterpyloriintheperiod20132020resultsoftheeuropeanregistryonhpylorimanagementhpeureg AT cosmeangel antibioticresistanceprevalenceandtrendsinpatientsinfectedwithhelicobacterpyloriintheperiod20132020resultsoftheeuropeanregistryonhpylorimanagementhpeureg AT puigignasi antibioticresistanceprevalenceandtrendsinpatientsinfectedwithhelicobacterpyloriintheperiod20132020resultsoftheeuropeanregistryonhpylorimanagementhpeureg AT megraudfrancis antibioticresistanceprevalenceandtrendsinpatientsinfectedwithhelicobacterpyloriintheperiod20132020resultsoftheeuropeanregistryonhpylorimanagementhpeureg AT omoraincolm antibioticresistanceprevalenceandtrendsinpatientsinfectedwithhelicobacterpyloriintheperiod20132020resultsoftheeuropeanregistryonhpylorimanagementhpeureg AT gisbertjavierp antibioticresistanceprevalenceandtrendsinpatientsinfectedwithhelicobacterpyloriintheperiod20132020resultsoftheeuropeanregistryonhpylorimanagementhpeureg AT antibioticresistanceprevalenceandtrendsinpatientsinfectedwithhelicobacterpyloriintheperiod20132020resultsoftheeuropeanregistryonhpylorimanagementhpeureg |